LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer

Francesca Lovat, Hideshi Ishii, Monica Schiappacassi, Matteo Fassan, Mattia Barbareschi, Enzo Galligioni, Pierluigi Gasparini, Gustavo Baldassarre, Carlo M. Croce, Andrea Vecchione

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The Leucine Zipper Tumor Suppressor 1 (LZTS1) is a tumor suppressor gene, located at chromosome 8p22, which is frequently altered in human cancer. In normal tissue, its ubiquitous expression regulates cell mitosis by the stabilization of microtubule networks. LZTS1-deficient mouse embryonic fibroblasts have been shown to have an accelerated mitotic progression, and a higher resistance to taxanes, microtubule-stabilizing drugs. We investigate the role of Lzts1 in paclitaxel-resistance in breast cancer cells. Downregulation of Lzts1 expression significantly decreases sensitivity to paclitaxel in vitro. We further analyzed Lzts1 expression by immunohistochemistry in 270 primary breast cancer samples and 16 normal breast specimens. Lzts1 was significantly downregulated in breast cancer samples and its deregulation was associated with a higher incidence of tumor recurrence, and to a worse overall survival. Moreover, Lzts1-negative tumors were associated with unfavorable outcome after taxanes-based therapy. Thus our data suggest that Lzts1 deregulation is involved in breast cancer and its immunohistochemical evaluation may serve as a prognostic factor for breast cancer therapy.

Original languageEnglish
Pages (from-to)970-977
Number of pages8
JournalOncotarget
Volume5
Issue number4
Publication statusPublished - 2014

Fingerprint

Leucine Zippers
Paclitaxel
Down-Regulation
Breast Neoplasms
Taxoids
Neoplasms
Microtubules
Tumor Suppressor Genes
Mitosis
Breast
Fibroblasts
Chromosomes
Immunohistochemistry
Recurrence
Survival
Incidence
Therapeutics
Pharmaceutical Preparations

Keywords

  • Breast cancer
  • Lzts1/Fez1
  • Taxanes

ASJC Scopus subject areas

  • Oncology
  • Medicine(all)

Cite this

Lovat, F., Ishii, H., Schiappacassi, M., Fassan, M., Barbareschi, M., Galligioni, E., ... Vecchione, A. (2014). LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer. Oncotarget, 5(4), 970-977.

LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer. / Lovat, Francesca; Ishii, Hideshi; Schiappacassi, Monica; Fassan, Matteo; Barbareschi, Mattia; Galligioni, Enzo; Gasparini, Pierluigi; Baldassarre, Gustavo; Croce, Carlo M.; Vecchione, Andrea.

In: Oncotarget, Vol. 5, No. 4, 2014, p. 970-977.

Research output: Contribution to journalArticle

Lovat, F, Ishii, H, Schiappacassi, M, Fassan, M, Barbareschi, M, Galligioni, E, Gasparini, P, Baldassarre, G, Croce, CM & Vecchione, A 2014, 'LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer', Oncotarget, vol. 5, no. 4, pp. 970-977.
Lovat F, Ishii H, Schiappacassi M, Fassan M, Barbareschi M, Galligioni E et al. LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer. Oncotarget. 2014;5(4):970-977.
Lovat, Francesca ; Ishii, Hideshi ; Schiappacassi, Monica ; Fassan, Matteo ; Barbareschi, Mattia ; Galligioni, Enzo ; Gasparini, Pierluigi ; Baldassarre, Gustavo ; Croce, Carlo M. ; Vecchione, Andrea. / LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer. In: Oncotarget. 2014 ; Vol. 5, No. 4. pp. 970-977.
@article{cece20b08c6046dba70795920199abc9,
title = "LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer",
abstract = "The Leucine Zipper Tumor Suppressor 1 (LZTS1) is a tumor suppressor gene, located at chromosome 8p22, which is frequently altered in human cancer. In normal tissue, its ubiquitous expression regulates cell mitosis by the stabilization of microtubule networks. LZTS1-deficient mouse embryonic fibroblasts have been shown to have an accelerated mitotic progression, and a higher resistance to taxanes, microtubule-stabilizing drugs. We investigate the role of Lzts1 in paclitaxel-resistance in breast cancer cells. Downregulation of Lzts1 expression significantly decreases sensitivity to paclitaxel in vitro. We further analyzed Lzts1 expression by immunohistochemistry in 270 primary breast cancer samples and 16 normal breast specimens. Lzts1 was significantly downregulated in breast cancer samples and its deregulation was associated with a higher incidence of tumor recurrence, and to a worse overall survival. Moreover, Lzts1-negative tumors were associated with unfavorable outcome after taxanes-based therapy. Thus our data suggest that Lzts1 deregulation is involved in breast cancer and its immunohistochemical evaluation may serve as a prognostic factor for breast cancer therapy.",
keywords = "Breast cancer, Lzts1/Fez1, Taxanes",
author = "Francesca Lovat and Hideshi Ishii and Monica Schiappacassi and Matteo Fassan and Mattia Barbareschi and Enzo Galligioni and Pierluigi Gasparini and Gustavo Baldassarre and Croce, {Carlo M.} and Andrea Vecchione",
year = "2014",
language = "English",
volume = "5",
pages = "970--977",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "4",

}

TY - JOUR

T1 - LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer

AU - Lovat, Francesca

AU - Ishii, Hideshi

AU - Schiappacassi, Monica

AU - Fassan, Matteo

AU - Barbareschi, Mattia

AU - Galligioni, Enzo

AU - Gasparini, Pierluigi

AU - Baldassarre, Gustavo

AU - Croce, Carlo M.

AU - Vecchione, Andrea

PY - 2014

Y1 - 2014

N2 - The Leucine Zipper Tumor Suppressor 1 (LZTS1) is a tumor suppressor gene, located at chromosome 8p22, which is frequently altered in human cancer. In normal tissue, its ubiquitous expression regulates cell mitosis by the stabilization of microtubule networks. LZTS1-deficient mouse embryonic fibroblasts have been shown to have an accelerated mitotic progression, and a higher resistance to taxanes, microtubule-stabilizing drugs. We investigate the role of Lzts1 in paclitaxel-resistance in breast cancer cells. Downregulation of Lzts1 expression significantly decreases sensitivity to paclitaxel in vitro. We further analyzed Lzts1 expression by immunohistochemistry in 270 primary breast cancer samples and 16 normal breast specimens. Lzts1 was significantly downregulated in breast cancer samples and its deregulation was associated with a higher incidence of tumor recurrence, and to a worse overall survival. Moreover, Lzts1-negative tumors were associated with unfavorable outcome after taxanes-based therapy. Thus our data suggest that Lzts1 deregulation is involved in breast cancer and its immunohistochemical evaluation may serve as a prognostic factor for breast cancer therapy.

AB - The Leucine Zipper Tumor Suppressor 1 (LZTS1) is a tumor suppressor gene, located at chromosome 8p22, which is frequently altered in human cancer. In normal tissue, its ubiquitous expression regulates cell mitosis by the stabilization of microtubule networks. LZTS1-deficient mouse embryonic fibroblasts have been shown to have an accelerated mitotic progression, and a higher resistance to taxanes, microtubule-stabilizing drugs. We investigate the role of Lzts1 in paclitaxel-resistance in breast cancer cells. Downregulation of Lzts1 expression significantly decreases sensitivity to paclitaxel in vitro. We further analyzed Lzts1 expression by immunohistochemistry in 270 primary breast cancer samples and 16 normal breast specimens. Lzts1 was significantly downregulated in breast cancer samples and its deregulation was associated with a higher incidence of tumor recurrence, and to a worse overall survival. Moreover, Lzts1-negative tumors were associated with unfavorable outcome after taxanes-based therapy. Thus our data suggest that Lzts1 deregulation is involved in breast cancer and its immunohistochemical evaluation may serve as a prognostic factor for breast cancer therapy.

KW - Breast cancer

KW - Lzts1/Fez1

KW - Taxanes

UR - http://www.scopus.com/inward/record.url?scp=84897469173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897469173&partnerID=8YFLogxK

M3 - Article

C2 - 24448468

AN - SCOPUS:84897469173

VL - 5

SP - 970

EP - 977

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 4

ER -